87S:FRA
Roivant Sciences Ltd
€28.88
arrow_downward
-0.17%(-0.050) 1D
Sep 4, 10:00:00 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 87S...
Open
€29.21
High
€29.23
Low
€28.88
Mkt. cap
25.23B
Avg. vol.
0.00
Volume
0.00
52-wk high
€32.21
52-wk low
€10.40
No. of employees
721
Open
€29.21
High
€29.23
Low
€28.88
Mkt. cap
25.23B
Avg. vol.
0.00
Volume
0.00
52-wk high
€32.21
52-wk low
€10.40
No. of employees
721
News stories
From web sources and news partners
Investing.com
·
11 hours ago
Roivant to present phase 2 pulmonary hypertension study results
Profile
Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel. Wikipedia
About Roivant Sciences Ltd